Planar Wart Removal
61Planar Wart Removal Tips
Planar Wart Removal Tips
A planar wart is one that is generally in one's foot – most likely the heel area- and what that is quite painful. Such a wart can make walking difficult and even wearing socks or shoes like sneakers can aggravate the condition. There are many different forms of planar wart removal you can try. The following are just some of the many options available to you.
Over-the-Counter Salicylic Acid
One great form of planar wart removal is to use some salicylic acid. This item is available in most drug stores and has proven to be successful in removing the warts in three to four weeks. Once you purchase this item, you need to apply it to the wart twice a day and should also take the time to rub off any dead skin that may be around the wart. Often, you can apply the acid for planar wart removal as a patch or in the form of a solution. Use a nail file to remove the dead skin and try not to touch the area with your bare hands. When using the acid for planar wart removal, be careful to concentrate it only on the infected area: the acid can irritate unaffected skin.
Liquid Nitrogen
Often called cryotherapy, liquid nitrogen is a great mode of planar wart removal. Here, a doctor will freeze a person's wart with the nitrogen. To do this, they apply the item to the wart using a cotton-tip applicator. Though the treatment can be quite painful, it has been known to help folks remove the wart more quickly than other forms of planar wart removal. Often, a doctor will suggest that other methods be tried first, especially if this is a person's first wart. This treatment is much more expensive than other forms of planar wart removal that are available today.
Duct Tape
One of the easiest ways to rid yourself of a planar wart is to use duct tape. To do this, you put the tape on the wart and leave it in place for a week. After this period of time, you wash the area, dry it, and then rub off the wart skin with a nail file. If you use this kind of planar wart removal, expect it to take about six to eight weeks for it to work. Duct tape is one of the least expensive methods of planar wart removal and has been proven just as effective as other treatments.
PrintShare it! — Rate it: up down flag this hub
Planar Wart Removal in the News
- Live latin rock, warts and allChicago Tribune2 days ago
Catch local bands as they get their shot onstage and on camera with 'E N E Chicago Rocks' Quiet on the set!
- The Gruffalo, warts and all, voted top bedtime story by radio listenersYorkshire Post16 hours ago
Didn't you know... the nation's favourite bedtime story was yesterday revealed to be The Gruffalo.
- Warts and all, the gruffalo is favouriteThe Scotsman23 hours ago
THE Gruffalo has been named as the nation's favourite bedtime story.
- Helix BioPharma Corp. Completes Enrollment In Its Phase II Trial Of Topical Interferon Alpha-2b In Patients With Ano ...Medical News Today34 hours ago
Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial. The double-blind and placebo-controlled Phase II trial is underway at multiple centers in Germany and Sweden.
- KidsPost: Ever wondered if frogs cause warts?Washington Post6 days ago
When I was a kid, my mom told me not to touch frogs because I would get warts. Although I did most of the things my mom told me, touching frogs was way too tempting. As a result, I must have handled thousands of the amphibians by my 10th birthday. And even though I did not get warts from frogs, I...
- Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano ...ITNews2 days ago
AURORA, Ontario, November 5 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced today that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial.






